Benjamin Wallfisch

Popular Topics

Food, Drugs, Healthcare, Life Sciences Corporate/Commercial Law Government, Public Sector

Benjamin Wallfisch’s articles from Polsinelli LLP are most popular:

with readers working within the Healthcare industries
within Food, Drugs, Healthcare and Life Sciences topic(s)
in North America, United States and Europe

DETAILS

United States

www.polsinelli.com

+1 212 6840199

AUTHORS CONTENT

FCA Recoveries Hit $6.8 Billion As Courts Question The Future Of The Qui Tam Authority

United States Government

OIG Reels In The Employment Safe Harbor: Recent Advisory Opinion Signals Risks For Sign-On Bonuses In Home Care

United States Healthcare

OIG's Latest Advisory Opinion: When Is A Discount A "Discount"?

United States Healthcare

Turning Insight Into Action: A Life Sciences Playbook For 2026

United States Commercial

CMS Proposes GLOBE And GUARD Drug Pricing Models To Reduce Medicare Costs

United States Healthcare

CMS Finalizes Sweeping Reforms To Skin Substitute Payments Amid Rising Costs And Enforcement Activity

United States Healthcare

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More